Graphite Bio, Inc.

Graphite Bio, Inc.verified

GRPH

Price:

$3.18

Market Cap:

$204.43M

Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the...[Read more]

Industry

Biotechnology

IPO Date

2021-06-25

Stock Exchange

NASDAQ

Ticker

GRPH

The PE Ratio as of June 2026 (TTM) for Graphite Bio, Inc. (GRPH) is -0.21

According to Graphite Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.21. This represents a change of -97.87% compared to the average of -9.72 of the last 4 quarters.

Graphite Bio, Inc. (GRPH) Historical PE Ratio (quarterly & annually)

How has GRPH PE Ratio performed in the past?

The mean historical PE Ratio of Graphite Bio, Inc. over the last ten years is -959.04. The current -0.21 PE Ratio has changed -97.84% with respect to the historical average. Over the past ten years (40 quarters), GRPH's PE Ratio was at its highest in in the June 2022 quarter at -0.95. The PE Ratio was at its lowest in in the March 2020 quarter at -1288.09.

Quarterly (TTM)
Annual

Average

-959.04

Median

-10.63

Minimum

-6665.00

Maximum

-1.44

Graphite Bio, Inc. (GRPH) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Graphite Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 755.20%

Maximum Annual PE Ratio = -1.44

Minimum Annual Increase = -99.84%

Minimum Annual PE Ratio = -6665.00

Quarterly (TTM)
Annual
YearPE RatioChange
2025-5.61-54.53%
2024-12.34755.20%
2023-1.44-87.33%
2022-11.3965.33%
2021-6.89-35.15%
2020-10.63-99.84%

Graphite Bio, Inc. (GRPH) Average PE Ratio

How has GRPH PE Ratio performed in the past?

The current PE Ratio of Graphite Bio, Inc. (GRPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.47

5-year avg

-7.54

10-year avg

-959.04

Graphite Bio, Inc. (GRPH) PE Ratio vs. Peers

How is GRPH’s PE Ratio compared to its peers?

Graphite Bio, Inc.’s PE Ratio is greater than Theseus Pharmaceuticals, Inc. (-3.32), greater than LakeShore Biopharma Co., Ltd (-0.48), greater than Vaccitech plc (-0.55), less than Zevra Therapeutics, Inc. (5.95), greater than Alaunos Therapeutics, Inc. (-1.06), greater than CARGO Therapeutics, Inc. Common Stock (-1.20), greater than Spectrum Pharmaceuticals, Inc. (-2.40), greater than F-star Therapeutics, Inc. (-3.79), greater than Graybug Vision, Inc. (-4.22), greater than eXoZymes, Inc. (-6.49),

Build a custom stock screener for Graphite Bio, Inc. (GRPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Graphite Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Graphite Bio, Inc. (GRPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Graphite Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Graphite Bio, Inc.'s PE Ratio?

How is the PE Ratio calculated for Graphite Bio, Inc. (GRPH)?

What is the highest PE Ratio for Graphite Bio, Inc. (GRPH)?

What is the 3-year average PE Ratio for Graphite Bio, Inc. (GRPH)?

What is the 5-year average PE Ratio for Graphite Bio, Inc. (GRPH)?

How does the current PE Ratio for Graphite Bio, Inc. (GRPH) compare to its historical average?